Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Cancer

Explore clinical trials studying Salivary Gland Cancer. Study availability and eligibility vary by location and protocol.

31 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Cancer trial results

Active, not recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, not recruiting

APG-115 in Salivary Gland Cancer Trial

NCT03781986

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +12 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

Amivantamab in Adenoid Cystic Carcinoma

NCT05074940

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +11 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Rogel Cancer Center - University of Michigan Health Ann Arbor, Michigan, United States
  • Washington University - School of Medicine in St. Louis St Louis, Missouri, United States
View Trial Details
Active, not recruiting

Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

NCT04209660

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +12 more
Locations
  • Baptist Alliance MCI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Completed

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

NCT05694819

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
View Trial Details
Completed

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

NCT03172624

Conditions
Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details

Related conditions